Skip to main content
logo
Lantheus Holdings, Inc. (LNTH)
NASDAQ: LNTH · Real-Time Price · USD
100.73
+0.05 (0.05%)
At close: Aug 12, 2026, 4:00 PM EDT
101.00
+0.27 (0.27%)
After-hours: Aug 12, 2026, 7:58 PM EDT

Revenue Breakdown

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
PYLARIFY Revenue
962.11M989.12M1.06B
Other Radiopharmaceutical Oncology Revenue
--384.00K
Total Radiopharmaceutical Oncology Revenue
962.11M989.12M1.06B
DEFINITY Revenue
340.00M330.25M317.79M
Neuraceq Revenue
126.50M51.45M-
TechneLite Revenue
-86.80M95.49M
Other Precision Diagnostics Revenue
-24.62M24.23M
Total Precision Diagnostics Revenue
520.90M493.11M437.51M
Strategic Partnerships and Other Revenue
73.30M59.38M38.18M
Revenue (Total)
1.56B1.54B1.53B

Revenue Breakdown 2

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
Product Revenue
1.51B1.51B1.52B
License and Royalty Revenue
43.42M34.04M9.13M
Revenue (Total)
1.56B1.54B1.53B